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and management
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and Marian C Horzinek 
Agent properties
Aspergillosis is caused by fungal organisms of the genus Aspergillus.
Aspergillus species are ubiquitous saprophytes. The organism is occa-
sionally also isolated from healthy animals. 
There is some confusion in the nomenclature of these fungi. Species
identification only on the basis of phenotypic features probably leads
to overidentification of Aspergillus fumigatus. Some species initially
identified as A fumigatus by conventional methods now have been 
classified as Neosartorya species, Aspergillus lentulus and Aspergillus









included in the 
A fumigatus complex
are responsible for the
majority of infections
in cats, but Aspergillus
flavus, Aspergillus nidulans, Aspergillus niger and Aspergillus terreus have
also been detected. Recently, A udagawae, a rare opportunistic
pathogen, was identified in a cat causing fatal orbital aspergillosis.2
Epidemiology
Aspergillus species are found worldwide in soil and decaying vegeta-
tion. All mammals, including humans, are susceptible to aspergillosis.
Immunosuppressed persons (eg, by human immunodeficiency virus
infection) are particularly prone to acquiring the disease. Cats and other
animals are infected through contamination of the environment. Direct
transmission does not occur – thus, aspergillosis is not a zoonosis. 
European Advisory Board on Cat Diseases
The European Advisory Board on Cat Diseases (ABCD) is a body
of experts in immunology, vaccinology and clinical feline medicine
that issues guidelines on prevention and management of feline
infectious diseases in Europe, for the benefit of the health and
welfare of cats. The guidelines are based on current scientific
knowledge of the diseases and available vaccines concerned.
The latest version of the aspergillosis in cats 
guidelines is available at www.abcd-vets.org
Overview: Aspergillosis is a sporadic mycosis
that occurs worldwide in mammals and birds
and leads to a usually chronic, and only rarely
acute, disease that mainly affects the nasal
cavity and sinuses. 
Infection: Aspergillus species infections are
commonly associated with predisposing local or
systemic factors. Local disease can spread and
involve the central nervous system or the lungs.
Some Aspergillus species can also disseminate,
causing systemic infections. In contrast to dogs,
in which (nasal) aspergillosis is relatively
common, aspergillosis is rare in cats, but
considered an emerging infection. 
Clinical signs: There are two clinical forms 
of aspergillosis in cats, the sinonasal form
(characterised by signs of chronic nasal
infection) and the newly emerging, more invasive
sino-orbital form (characterised by signs of
orbital and surrounding tissue invasion). 
Sino-orbital involvement has been described
now in approximately half of the reported cases.
Disease management: Treatment should consist
of local and systemic antifungal therapy.
*The ABCD is grateful to Professor Lluís Ferrer, of the Foster
Hospital for Small Animals, Cummings School of Veterinary
Medicine, Tufts University, USA, who, though not a member
of the Board, contributed to this article.
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Aspergillosis occurs worldwide. Most of the
cases have been reported from Australia, 
but feline aspergillosis has been described 
in North America, the United Kingdom,
Switzerland, Germany, Japan and Italy.1,3–5 No
age or sex predisposition has been detected. 
A predisposition was found in brachycephalic
breeds, especially Persian and Himalayan
cats.1,3,6,7 Reduced drainage of upper respira-
tory secretions has been suggested as a predis-
posing factor.8 Additional suggested factors
include innate defects of mucosal immunity,
previous viral upper respiratory tract infec-
tions, and antibiotic treatment.3 A relationship
between sino-orbital aspergillosis and lym-
phoplasmacytic rhinitis in a cat treated with
oral prednisone has been suggested,4 indicat-
ing that immunosuppression may play a role.
No association between aspergillosis and
feline retrovirus infections has been reported.9
Pathogenesis
Infection usually occurs from Aspergillus
species accumulated in pet food and litter. The
spores are inhaled and deposited in the sino sal
cavity, the primary site of infection. The fungus
must adhere to the respiratory epithelium, 
penetrate it, destroy surrounding cells, and
resist phagocytosis. Aspergillus species conidia
bind to various cell surface proteins using 
specific adhesion molecules, such as 
hydro phobins. A fumigatus also produces an
immuno suppressive toxin (gliotoxin) that
inhibits macrophage phagocytosis. Other
metabolites impair mucociliary action and pro-
long the organisms’ epithelial resistance, while
enzymes (eg, proteases) help to invade tissues.
Figure 1 Exophthalmos of the left eye in a cat with a left
retrobulbar fungal granuloma (sino-orbital aspergillosis). There
is prolapse of the third eyelid. A partial lateral tarsorrhaphy was
performed to prevent exposure keratitis. Courtesy of Vanessa
Barrs, University Veterinary Teaching Hospital, Sydney, Australia
Figure 2 Right
exophthalmos, third eyelid
prolapse and oedema and
swelling of the right side of
the face in a cat with a right
retrobulbar and paranasal
fungal granuloma. Courtesy
of Vanessa Barrs, University
Veterinary Teaching Hospital,
Sydney, Australia
Figure 3 Ventral expansion of retrobulbar fungal granulomas
causing a mass effect in the pterygopalatine fossa in a cat
with a right retrobulbar fungal granuloma (arrow). Courtesy of
Vanessa Barrs, University Veterinary Teaching Hospital, Sydney,
Australia
Figure 4 Thoracic radiograph (laterolateral view) of a cat with pulmonary aspergillosis,
confirmed at necropsy. Courtesy of Katrin Hartmann, Ludwig Maximilians University, Munich,
Germany
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There are two clinical forms of aspergillosis in cats,
the sinonasal and the newly emerging, 
more invasive sino-orbital form. 
 at Universite de Liege on September 3, 2013jfm.sagepub.comDownloaded from 
REV IEW / ABCD guidelines on aspergillosis
Clinical signs
Aspergillosis occurs in two main forms in
cats, sinonasal aspergillosis (SNA) and sino-
orbital aspergillosis (SOA). SNA is charac-
terised by more local signs of chronic nasal
infection, such as sneezing, uni- or bilateral
serous to mucopurulent nasal discharge, and
sometimes epistaxis. Stertorous breathing,
granuloma formation, soft tissue masses pro-
truding from the nares, and bone lysis are less
frequent abnormalities.3,7
SOA is the more invasive form. The clinical
manifestation depends on the invading fungal
species, and SOA probably represents an
extension of SNA to orbital and subcutaneous
tissues, caused by invasive Aspergillus species,
like Neosartorya species. Most cats with SOA
indeed have a history of nasal discharge, and
nasal lesions have been seen at necropsy in
addition to lysis of the orbital lamina identi-
fied using imaging techniques.1,4,6 SOA is
characterised by signs of orbital and sur-
Figure 6 (a) Growth of A fumigatus on malt extract agar (MEA). Colonies are typically olive
green and velvety due to rapid sporulation. (b) By contrast some species of Aspergillus in the 
A fumigatus complex that cause sino-orbital aspergillosis are slow to sporulate and the
colonies appear whitish until sporulation occurs. Courtesy of Vanessa Barrs, University Veterinary
Teaching Hospital, Sydney, Australia
Figure 5 (a) Haematoxylin and eosin stained section of a retrobulbar fungal granuloma consisting of a large central granuloma
surrounded by smaller satellite granulomas. Centrally each granuloma contains necrotic cellular debris within which branching,
septate fungal hyphae are confined, as seen on the Grocott stained section (b). There are surrounding zones of neutrophils and
eosinophils, macrophages, fibroblasts and a peripheral cuff of lymphocytes and plasma cells. Courtesy of Vanessa Barrs, University
Veterinary Teaching Hospital, Sydney, Australia
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rounding tissue invasion, including unilateral
exophthalmos, third eyelid prolapse (Figure
1), conjunctival hyperaemia and keratitis
(Figure 2). In some cases, a mass in the
pterygo palatine fossa (Figure 3) or an ulcera-
tion of the hard palate, or even extension and
destruction of the nasal cavity (sometimes
with swelling and skin ulcers), can be seen.
The central nervous system can be involved
leading to neurological signs, peripheral
vestibular signs and blindness, and regional
lymphadenopathy and fever can occur. 
Atypical cases of aspergillosis have been
reported, including pneumonia (Figure 4) and
pyothorax in a diabetic cat,10 a cat with 
generalised systemic infection,5 and a cat with
ulcerative keratitis.11
Laboratory abnormalities in cats with
aspergillosis are non-specific and the result of
chronic inflammation. Hyperglobulinaemia is
the most frequently reported abnormali-
ty.1,6,12,13
Immunity
Immunity against Aspergillus species infection
is poorly understood. Many cats develop anti-
bodies, but some cats produce only low or
undetectable antibody levels (mostly in cases
of A fumigatus infection).7 Additionally, cats
can produce antibodies without clinical dis-
ease, which is likely the result of non-invasive
mucous membrane colonisation that occurs in
many healthy cats.
Diagnosis
Diagnosis is based on demonstration of fungal
hyphae by cytology or histology (Figure 5) and
definitive confirmation by fungal culture
(Figure 6). Advanced imaging techniques
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nance imaging [MRI]) are
helpful to assess disease
extension and to find the 
best location for obtaining
diagnostic samples during
rhinoscopy (Figure 7) [EBM
grade IV].7 CT and MRI are
also important tools to rule
out neoplasia. However, in a
study including 10 cats (five
with aspergillosis), CT find-
ings neither allowed dis crim -
ination between different
fungal infections nor distin-
quished aspergillosis from
neoplasia [EBM grade III].14
Direct detection of the organism
A definitive diagnosis is usually obtained by
histology and detection of the organism in
biopsy specimens obtained by rhinoscopy
(Figure 8) or nasal cavity lavage techniques
[EBM grade III]. As Aspergillus species can be
found on mucosal surfaces of healthy animals,
infection can only be diagnosed if samples are
taken from a deep layer of tissue, and it is
important to take samples directly from affect-
ed areas. Within tissues, Aspergillus species
grows with branched, septate hyphae (2–5 µm
diameter). 
Cytology of fine needle aspirates of orbital
or palatine lesions can sometimes demon-
strate fungal hyphae, but a negative result
does not rule out aspergillosis. 
If cultured on special growth media (eg,
Sabouraud agar), Aspergillus species form
mycelia with clearly visible conidia on conid-
iophores within 5–7 days (Figure 9). A single
positive culture from swabs or secretions
without histological evidence is not diagnos-
tic, as the organism is ubiquitous. 
Polymerase chain reaction has recently been
offered for the detection of Aspergillus species,
but its relevance in veterinary medicine is not
yet clear.15
A new non-invasive test is the measurement
of serum galactomannan, a polysaccharide
fungal cell wall component by one-stage,
immunoenzymatic sandwich ELISA. Overall,
the test is moderately specific, but has a poor
sensitivity and, thus, is not very helpful to
rule out the disease [EBM grade IV].16
Detection of antibodies
Aspergillus species antibody testing for cats is
available on the basis of agar gel immuno -
diffusion, latex agglutination, counter-immuno -
electrophoresis or ELISA. Due to high numbers
of positive results in healthy cats (up to 15%),
positive test results should always be evaluated
in combination with clinical signs and histology
results. Negative results should also be inter-
preted with caution, as some individuals only
produce low amounts of antibodies (mostly
when infected with A fumigatus) that might be
missed. Antibody testing was not useful in two
of four cats with fungal rhinitis [EBM grade
IV].7 Nevertheless, antibody measurement can
give useful hints in some potentially affected
cats when interpreted carefully and can be very
helpful in the decision to perform more inva-
sive diagnostics [EBM grade III].1
Treatment
No prospective controlled studies exist on the
treatment of aspergillosis in cats, and the
available information is based only on retro-
spective case reports. In general, response to
therapy and prognosis in SNA is good when
intensive and sufficiently long treatment is
instituted. Response to treatment is less suc-
cessful in invasive SOA, and the prognosis is
worse.8 In systemic aspergillosis, the progno-
sis is generally poor. 
In SNA, the treatment of choice is a 
Figure 8 Rhinoscopy being performed in a cat with chronic
nasal discharge to obtain samples for histology and culture 
of Aspergillus species. Courtesy of Bianka Schulz, Ludwig
Maximilians University, Munich, Germany
Figure 9 A fumigatus conidial heads from a squash
preparation of fungal plaques (inset) in a Scottish shorthair
cat with sinonasal aspergillosis. Courtesy of Vanessa Barrs,
University Veterinary Teaching Hospital, Sydney, Australia
Figure 7 Rhinoscopic
findings in a cat with
sinonasal aspergillosis.
Courtesy of Bianka Schulz,
Ludwig Maximilians University,
Munich, Germany
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Drug Dose Comments
Clotrimazole Single or multiple intranasal local instillation
Itraconazole 5 mg/kg q12h PO Suggested drug of choice after local treatment (should be given for at least 2–3 months or 1 month
beyond clinical cure)
Fluconazole 1.25–2.5 mg/kg q12h PO Should be considered in cases of CNS infection (should be given for at least 2–3 months or 1 month
beyond clinical cure)
PO = oral, CNS = central nervous system
Systemic treatment for aspergillosis (most commonly used drugs)Table 1
Figure 10 Local infusion of
clotrimazole under general
anaesthesia in a cat with
sinonasal aspergillosis.






Courtesy of Vanessa Barrs,
University Veterinary Teaching
Hospital, Sydney, Australia
com bination of systemic antifungal treatment 
(itraconazole, fluconazole, amphotericin B,
posaconazole, voraconazole or terbinafine) in
combination with local therapy, using clo -
trimazole or enilconazole intranasal infusions
under general anaesthesia (Table 1) [EBM
grade III]. Systemic antifungal treatment
should be administered over several months,
and owners should be informed early about
the long treatment required. Based on case
series, best choices for systemic treatment are
itraconazole (5 mg/kg q12h PO) alone or in
combination with amphotericin B, or the new
azoles posaconazole (2.5–4.5 mg/kg q12h PO)
and voriconazole (5–12 mg/kg q24h PO) [EBM
grade III]. Voriconazole looks like a promising
drug, but can result in adverse neurological
effects, including ataxia, paraplegia and cra-
nial nerve deficits.17 Therefore, voriconazole
should only be used in selected cases until
more studies on safety in cats have been per-
formed. In cases of central nervous system
involvement, fluconazole (1.25–2.5 mg/kg
q12h PO) is a good option.
The local treatment is usually performed with
infusion of clotrimazole (Figure 10). This
requires access to affected tissues and is less
effective when the infection occurs deep in the
tissue. Surgical debridement of gross fungal
lesions (Figure 11) before local treatment is rec-
ommended to increase the chance of complete
remission [EBM grade III].8,18A single intranasal
infusion of clotrimazole led to long-term resolu-
tion of clinical signs in two studies, involving
three cats3 and two cats [EBM grade IV].19
Multiple local treatments probably are better to
reduce relapses. Systemic treatment solely
without local infusions is not as successful. Four
cats with fungal rhinitis were treated with itra-
conazole orally; when therapy was discontin-
ued, clinical signs recurred [EBM grade IV].7
In SOA, treatment is more difficult. In severe
SOA, surgery is necessary – either lateral
orbitotomy or eye enucleation.13 In a series of
three cases with SOA, two cats were treated
with voriconazole and surgery with successful
results [EBM grade IV].13 Other drugs have
been used in cats with SOA, including
echinocandins in two cats, caspofungin as 
single treatment with good results in one cat
[EBM grade IV],1 and micafungin in one cat
showing no success.2 In one case, posacona-
zole cured a cat with SOA which had not
responded to itraconazole plus amphotericin B
[EBM grade III];12 in another case, long clinical
remission was achieved with posaconazole
after no improvement with itraconazole plus
terbinafine treatment [EBM grade III].18
If only the eyes are involved, local treatment
can be successful. An 8-year-old cat that 
suffered from ulcerative keratitis with stromal
loss, stromal infiltrate, corneal oedema, 
peri limbal vascularisation and miosis was
treated with 1% voriconazole solution, and
the keratomycosis resolved successfully [EBM
grade III].11
Although associated with a poor prognosis,
one cat with pulmonary aspergillosis was suc-
cessfully managed with a combination of sur-
gery (lung lobectomy and chest drainage) and
systemic itraconazole therapy for 1 month
[EBM grade IV].10
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< Aspergillosis is a fungal disease occurring worldwide; it is less
common in cats than in dogs.
< Animals are infected through contamination from the
environment; direct transmission does not occur.
< Aspergillosis is not a zoonosis; humans also acquire the
infection from the environment.
< In cats, aspergillosis occurs in two main forms: the sinonasal,
and the more invasive sino-orbital form.
< Diagnosis relies on detection of the organism in affected
tissues, usually by cytology or histology.
< Treatment should consist of local and systemic antifungal
therapy.
< When treated aggressively and for long enough, the prognosis
for sinonasal aspergillosis is good; it is guarded in sino-orbital, 
and poor in systemic aspergillosis.
KEY POINTS
Available online at jfms.com 
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Prevention
Due to the ubiquitous occurrence and the high
resistance of the pathogen, prophylaxis is
hardly possible. Although an association of
aspergillosis with immunosuppression is 
not clearly established, prophylactic measures
in immunocompromised animals consist of
reducing exposure. Therefore, immunosup-
pressed animals should be kept indoors.
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